Is it time for population genetic testing for BRCA1 and BRCA2 in the Jewish population?K., MetcalfeA., PollR., RoyerM., LlacuachaquiA., TulmanP., SunS., Narod
Barbara A. Koenig et al., Genetic Testing for BRCA1 and BRCA2: Recommendations of the Stanford Program in Genomics, Ethics, and Society, 7 J. WOMEN'S HEALTH 531 (1998).Koenig, B. A. et al. (1998), `Genetic testing for BRCA1 and BRCA2: Recommenda- tions of the Stanford Program ...
It is concluded that women with cancer who participate in BRCA1 and BRCA2 testing need to receive clear information about the meaning and implications of the different types of test results. Some recommendations for clinical practice are discussed. 展开 ...
BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. Seattle: University of Washington; 2016. 32. Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of ...
METHODS: : Single institution retrospective chart review of patients with ovarian cancer who underwent BRCA1/BRCA2 genetic testing. RESULTS: Thirty-three percent of our sample (n = 100) were seen for genetic counseling after ovarian cancer recurrence. In four cases, genetic test results were ...
Genetic counseling via telephone (TC) has emerged as a potential avenue of care for women at risk of breast and ovarian cancers and open to BRCA1 and BRCA2 genetic testing. However, although TC has been shown to be on level wit...
Testing for mutations in hereditary breast/ovarian cancer genes (BRCA1/BRCA2) is appropriate for a limited group of high-risk individuals, such as some breast cancer survivors. It is not known if survivors obtain information regarding genetic testing or whether physicians play a role in the ...
“Pathway’s mission is to ensure that people in need receive genetic testing regardless of their economic or insurance status,” said Jim Plante,Pathway Genomics’ founder and CEO. “Offering the industry’s bestBRCAgenetic test and making it accessible to a wide range of people is a vital ...
Aetna considers genetic testing for CPVT medically necessary for the following indications: Member has either of the following: A first-degree relative (i.e., parent, full-sibling, child) with a confirmed CPVT mutation (Note: Test for known familial mutation); or A structurally normal heart an...
3, Anne-Deborah Bouhnik, MSc, PhD2,3, François Eisinger, MD1–3, Christine Lasset, MD, PhD4, Emmanuelle Fourme, MD5,6 and Catherine Noguès, MD5,6 Purpose: This study aimed to measure patients' smoking patterns for 5 years after BRCA1/2 test result disclosure...